(*to be updated)

  •  Fabrizio Chiti,
    Experimental and Clinical Biomedical Sciences, University of Florence, Italy
    “The structural determinants of protein oligomer toxicity”
  • Astrid Gräslund,
    Department of Biochemistry and Biophysics, Stockholm University, Sweden.
    “Biophysical studies of the amyloid beta peptide involved in Alzheimer´s disease: molecular interactions, secondary structure conversions and aggregation”
  • Tuomas Knowles,
    Department of Chemistry, University of Cambridge, UK
    “Biophysical insights into protein aggregation”
  • Stephen C Meredith,
    The College of the University of Chicago, USA.
    “Brain Seeded ß-Amyoid Fibrils”
  • Stanley B. Prusiner,
    Institute for Neurodegenerative Diseases, University of California, USA.
    “A unifying role for prions in neurodegenerative diseases”
  • Daniel P. Raleigh,
    Department of Chemistry, Stony Brook University, USA
    “To be announced”
  • Roland Riek,
    ETH Zürich, Switzerland.
    “Structure-Activity Relationship of protein aggregates in health and disease”
  • James Shorter,
    Department of Biochemistry & Biophysics, University of Pennsylvania, USA.
    “Potentiated protein disaggregases to combat neurodegeneration”